Protein may hold key to restoring treatment response in drug-resistant neuroendocrine prostate cancer

It may be possible to restore drug-resistant neuroendocrine prostate cancer to a state that responds to treatment by depletion of a certain protein in cancer cells.

Integer acquires Pulse Technologies for $140M

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Integer Holdings Corporation bought Pulse

January 16, 2024

Research explores the health benefits of resistant starch in plant-based diets

Review evaluates the role of resistant starch in promoting health and its retention through food processing methods, highlighting the gap in current dietary intake and

March 22, 2024

New research links sphingolipids to heart disease and atherosclerosis

Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more, making it the focus of many

November 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.